The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The survey inspected ambulances operating throughout the city
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
Srichakra receives European Food Safety approval for its food-grade recycled rPET
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Go-ahead for pivotal clinical trial which is expected to commence by March
Subscribe To Our Newsletter & Stay Updated
